Is the female heart more sensitive to aldosterone for early remodeling?
Daniel A
DA
Duprez
D000450:Aldosterone / Q000494:pharmacology / Q000502:physiology*; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D004967:Estrogens / Q000502:physiology; D005260:Female; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D006352:Heart Ventricles / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic; D018161:Receptors, Mineralocorticoid / Q000502:physiology; D012494:Sampling Studies; D012727:Sex Characteristics; D014463:Ultrasonography; D020257:Ventricular Remodeling / Q000187:drug effects / Q000502:physiology*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D004967:Estrogens; D018161:Receptors, Mineralocorticoid; D000450:Aldosterone